Adverse Events From Cough and Cold Medications After a Market Withdrawal of Products Labeled for Infants

A voluntary market withdrawal of orally administered, over-the-counter cough and cold medications (CCMs) labeled for infants was announced in October 2007 because of concerns regarding limited evidence of efficacy and potential harmful effects of these products among young children.

This study assessed changes in CCM-related harm, as measured with national estimates of emergency department visits for CCM-related adverse events, among children after announcement of the withdrawal of orally administered, over-the-counter, infant CCMs

Read More